E-Ova L 2.5 Tablet
  1. Home
  2. Pharma Products
  3. Koye Pharmaceuticals Pvt Ltd
  4. E-Ova L 2.5 Tablet

E-Ova L 2.5 Tablet

E-Ova L 2.5 Tablet contains letrozole 2.5 mg, an aromatase inhibitor used in the treatment of breast cancer. It is mainly used for hormone-sensitive breast cancer in postmenopausal women. The tablet is taken orally as prescribed by a healthcare professional.

BUY NOW

Category

Letrozole works by reducing estrogen production in the body, which can slow or stop the growth of breast cancer cells that depend on estrogen. It may be used for early, locally advanced, or advanced breast cancer according to the prescribed treatment plan. Long-term treatment may require monitoring of bone mineral density and cholesterol levels because reduced estrogen can affect bone health and lipid levels. The dosage and treatment duration are individualized by the treating physician based on the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 5 Tablets
Manufacturer Koye Pharmaceuticals Pvt Ltd

Product Also Known As

E-Ova L 2.5 Tablet, E Ova L 2.5 Tablet, E-Ova L 2.5mg Tablet, E Ova L 2.5mg Tablet, Letrozole 2.5 mg Tablet, Letrozole 2.5mg Tablet, Letrozole Anticancer Tablet